ANN ARBOR, MI-Gov. John Engler says Pfizer Inc plans to invest $600 million to $800million in expanding its laboratories here within the next six years as a result of securing suitable land and state and local incentives. The company develops, manufactures and markets leading prescription medicines for humans and animals.

Michigan had been competing with other states to win the company’s investment. The company was attracted to Michigan by the state’s life sciences research institutions, existing company assets here and the ability to attractand retain high-tech employees, Engler says.

A 20-year Single Business Tax credit awarded to the company by the Michigan Economic Development Corp. was a factor in securing Pfizer’s expansion commitment. David Canter, Pfizer senior vice president and director says his company “now has the land we need to flourish. This will bring the city of Ann Arbor and the state economic growth and new jobs in the research and development sector.”

According to an economic analysis conducted by the University of Michigan, it is estimated the company’s projected investments will generate a total of 600 jobs directly by the company.

In addition to the SBT credit, the state is granting an abatement of the six-mill State Education Tax for 12 years valued a $10.7 million. The city of Ann Arbor has also approved a 12-year, $47.7 million property tax abatement for the company.

University of Michigan recently agreed to sell 55 acres of land near the school’s north campus to Pfizer for $27 million for future expansion.

Want to continue reading?
Become a Free ALM Digital Reader.

Once you are an ALM digital member, you’ll receive:

  • Unlimited access to GlobeSt and other free ALM publications
  • Access to 15 years of GlobeSt archives
  • Your choice of GlobeSt digital newsletters and over 70 others from popular sister publications
  • 1 free article* every 30 days across the ALM subscription network
  • Exclusive discounts on ALM events and publications

*May exclude premium content
Already have an account?


© 2023 ALM Global, LLC, All Rights Reserved. Request academic re-use from All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.



Join GlobeSt

Don't miss crucial news and insights you need to make informed commercial real estate decisions. Join now!

  • Free unlimited access to's trusted and independent team of experts who provide commercial real estate owners, investors, developers, brokers and finance professionals with comprehensive coverage, analysis and best practices necessary to innovate and build business.
  • Exclusive discounts on ALM and GlobeSt events.
  • Access to other award-winning ALM websites including and

Already have an account? Sign In Now
Join GlobeSt

Copyright © 2023 ALM Global, LLC. All Rights Reserved.